AIMS/HYPOTHESIS: Genetic investigations in the spontaneously diabetic (Type 2) Goto Kakizaki (GK) rat have identified quantitative trait loci (QTL) for diabetes-related phenotypes. The aims of this study were to refine the chromosomal mapping of a QTL ( Nidd/gk5) identified in chromosome 8 of the GK rat and to define a pathophysiological profile of GK gene variants underlying the QTL effects in congenics. METHODS: Genetic linkage analysis was carried out with chromosome 8 markers genotyped in a GKxBN F2 intercross previously used to map diabetes QTL. Two congenic strains were designed to contain GK haplotypes in the region of Nidd/gk5 transferred onto a Brown Norway (BN) genetic background, and a broad spectrum of diabetes phenotypes were characterised in the animals. RESULTS: Results from QTL mapping suggest that variations in glucose-stimulated insulin secretion in vivo, and in body weight are controlled by different chromosome 8 loci (LOD3.53; p=0.0004 and LOD4.19; p=0.00007, respectively). Extensive physiological screening in male and female congenics at 12 and 24 weeks revealed the existence of GK variants at the locus Nidd/gk5, independently responsible for significantly enhanced insulin secretion and increased levels of plasma triglycerides, phospholipids and HDL, LDL and total cholesterol. Sequence polymorphisms detected between the BN and GK strains in genes encoding ApoAI, AIV, CIII and Lipc do not account for these effects. CONCLUSIONS/ INTERPRETATION: We refined the localisation of the QTL Nidd/gk5 and its pathophysiological characteristics in congenic strains derived for the locus. These congenic strains provide novel models for testing the contribution of a subset of GK alleles on diabetes phenotypes and for identifying diabetes susceptibility genes.
AIMS/HYPOTHESIS: Genetic investigations in the spontaneously diabetic (Type 2) Goto Kakizaki (GK) rat have identified quantitative trait loci (QTL) for diabetes-related phenotypes. The aims of this study were to refine the chromosomal mapping of a QTL ( Nidd/gk5) identified in chromosome 8 of the GK rat and to define a pathophysiological profile of GK gene variants underlying the QTL effects in congenics. METHODS: Genetic linkage analysis was carried out with chromosome 8 markers genotyped in a GKxBN F2 intercross previously used to map diabetes QTL. Two congenic strains were designed to contain GK haplotypes in the region of Nidd/gk5 transferred onto a Brown Norway (BN) genetic background, and a broad spectrum of diabetes phenotypes were characterised in the animals. RESULTS: Results from QTL mapping suggest that variations in glucose-stimulated insulin secretion in vivo, and in body weight are controlled by different chromosome 8 loci (LOD3.53; p=0.0004 and LOD4.19; p=0.00007, respectively). Extensive physiological screening in male and female congenics at 12 and 24 weeks revealed the existence of GK variants at the locus Nidd/gk5, independently responsible for significantly enhanced insulin secretion and increased levels of plasma triglycerides, phospholipids and HDL, LDL and total cholesterol. Sequence polymorphisms detected between the BN and GK strains in genes encoding ApoAI, AIV, CIII and Lipc do not account for these effects. CONCLUSIONS/ INTERPRETATION: We refined the localisation of the QTL Nidd/gk5 and its pathophysiological characteristics in congenic strains derived for the locus. These congenic strains provide novel models for testing the contribution of a subset of GK alleles on diabetes phenotypes and for identifying diabetes susceptibility genes.
Authors: A Bottger; H A van Lith; V Kren; D Krenová; V Bílá; J Vorlícek; V Zídek; A Musilová; M Zdobinská; J M Wang; B F van Zutphen; T W Kurtz; M Pravenec Journal: J Clin Invest Date: 1996-08-01 Impact factor: 14.808
Authors: S Okuno; T K Watanabe; T Ono; Y Yamasaki; Y Goto; H Miyao; T Asai; N Kanemoto; K Oga; A Mizoguchi-Miyakita; T Takagi; E Takahashi; Y Nakamura; A Tanigami Journal: Genomics Date: 1999-12-15 Impact factor: 5.736
Authors: M T Bihoreau; L Sebag-Montefiore; R F Godfrey; R H Wallis; J H Brown; P A Danoy; S C Collins; M Rouard; P J Kaisaki; M Lathrop; D Gauguier Journal: Genomics Date: 2001-07 Impact factor: 5.736
Authors: Y Horikawa; N Oda; N J Cox; X Li; M Orho-Melander; M Hara; Y Hinokio; T H Lindner; H Mashima; P E Schwarz; L del Bosque-Plata; Y Horikawa; Y Oda; I Yoshiuchi; S Colilla; K S Polonsky; S Wei; P Concannon; N Iwasaki; J Schulze; L J Baier; C Bogardus; L Groop; E Boerwinkle; C L Hanis; G I Bell Journal: Nat Genet Date: 2000-10 Impact factor: 38.330
Authors: J Galli; L S Li; A Glaser; C G Ostenson; H Jiao; H Fakhrai-Rad; H J Jacob; E S Lander; H Luthman Journal: Nat Genet Date: 1996-01 Impact factor: 38.330
Authors: E S Lander; P Green; J Abrahamson; A Barlow; M J Daly; S E Lincoln; L A Newberg; L Newburg Journal: Genomics Date: 1987-10 Impact factor: 5.736
Authors: Leah C Solberg Woods; Brett C Woods; Caroline M Leitschuh; Sonia J Laurie; Howard J Jacob Journal: J Nutrigenet Nutrigenomics Date: 2012-06-19
Authors: Robert H Wallis; KeSheng Wang; Dominika Dabrowski; Leili Marandi; Terri Ning; Eugene Hsieh; Andrew D Paterson; John P Mordes; Elisabeth P Blankenhorn; Philippe Poussier Journal: Diabetes Date: 2007-03-27 Impact factor: 9.461
Authors: Stephan C Collins; Robert H Wallis; Steven P Wilder; Karin J Wallace; Karène Argoud; Pamela J Kaisaki; Marie-Thérèse Bihoreau; Dominique Gauguier Journal: Mamm Genome Date: 2006-06-12 Impact factor: 2.957
Authors: K Argoud; S P Wilder; M A McAteer; M T Bihoreau; F Ouali; P Y Woon; R H Wallis; A Ktorza; D Gauguier Journal: Diabetologia Date: 2006-09-16 Impact factor: 10.122
Authors: Samantha J Snow; Andres R Henriquez; Leslie C Thompson; Cynthia Fisher; Mette C Schladweiler; Charles E Wood; Urmila P Kodavanti Journal: Toxicol Appl Pharmacol Date: 2021-01-30 Impact factor: 4.219
Authors: Marc-Emmanuel Dumas; Céline Domange; Sophie Calderari; Andrea Rodríguez Martínez; Rafael Ayala; Steven P Wilder; Nicolas Suárez-Zamorano; Stephan C Collins; Robert H Wallis; Quan Gu; Yulan Wang; Christophe Hue; Georg W Otto; Karène Argoud; Vincent Navratil; Steve C Mitchell; John C Lindon; Elaine Holmes; Jean-Baptiste Cazier; Jeremy K Nicholson; Dominique Gauguier Journal: Genome Med Date: 2016-09-30 Impact factor: 11.117
Authors: Pamela J Kaisaki; Georg W Otto; Karène Argoud; Stephan C Collins; Robert H Wallis; Steven P Wilder; Anthony C Y Yau; Christophe Hue; Sophie Calderari; Marie-Thérèse Bihoreau; Jean-Baptiste Cazier; Richard Mott; Dominique Gauguier Journal: G3 (Bethesda) Date: 2016-11-08 Impact factor: 3.154